Live News Categoriesmarket

PHAR.AS (PHAR.AS) News

Track canonical SquawkNews coverage tagged to PHAR.AS, PHAR.AS. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol PHAR.AS Asset market Sector Markets 90 days 1 Updated Sep 22, 2026, 05:03 AM UTC Open live news feed

M Pharming posts positive Phase II topline data for leniolisib in immune dysregulation Pharming Group NV has reported positive topline Phase II data for its drug leniolisib, used to treat primary immunodeficiencies with immune dysregulation. The study indicated that the drug was generally well-tolerated an EQUITY | Sep 22, 2026, 05:03 AM UTC